ZAMBELLI ALBERTO

Gaudio, M., Vatteroni, G., De Sanctis, R., Gerosa, R., Benvenuti, C., Canzian, J., et al. (2025). Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologists. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 210(June 2025) [10.1016/j.critrevonc.2025.104681]. Dettaglio

Pala, L., Merlo, F., Sala, I., Pagan, E., Oriecuia, C., Specchia, C., et al. (2025). Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates. JOURNAL OF THE NATIONAL CANCER INSTITUTE [10.1093/jnci/djaf049]. Dettaglio

Provenzano, L., Dieci, M., Curigliano, G., Giuliano, M., Botticelli, A., Lambertini, M., et al. (2025). Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study. ANNALS OF ONCOLOGY, 36(7 (July 2025)), 762-774 [10.1016/j.annonc.2025.03.023]. Dettaglio

Lorini, L., Gili, R., Resteghini, C., Gerosa, R., Cecchi, L., Gurizzan, C., et al. (2025). Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer. ORAL ONCOLOGY, 164(May 2025) [10.1016/j.oraloncology.2025.107296]. Dettaglio

Canzian, J., Gentile, D., De Sanctis, R., Jacobs, F., Benvenuti, C., Gaudio, M., et al. (2025). Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patients. THE ONCOLOGIST, 30(5) [10.1093/oncolo/oyaf061]. Dettaglio